Literature DB >> 7831044

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.

R Klein1, B E Klein, S E Moss, K J Cruickshanks.   

Abstract

BACKGROUND: As part of a population-based study of diabetes mellitus, the incidence of macular edema over a 10-year period and its relation to various risk factors are examined.
METHODS: There were 891 younger-onset people with a diagnosis of having had diabetes before 30 years of age who were taking insulin at baseline examination and 987 older-onset people with a diagnosis of having had diabetes at 30 years of age or older who participated in baseline and 4-year examinations. Of these, 765 younger-onset and 533 older-onset people also participated in a 10-year examination. The presence of macular edema at baseline and follow-up examinations was determined from gradings of stereoscopic fundus photographs.
RESULTS: The incidence of macular edema over the 10-year period was 20.1% in the younger-onset group, 25.4% in the older-onset group taking insulin, and 13.9% in the older-onset group not taking insulin. The incidence of macular edema over the 10-year period was associated with higher levels of glycosylated hemoglobin and more severe retinopathy in both younger- and older-onset groups, and with being female and increased diastolic blood pressure in the older-onset group.
CONCLUSIONS: These data suggest a relatively high incidence of macular edema. The authors' data also suggest that a reduction in hyperglycemia may result in a beneficial decrease in the incidence of macular edema.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831044     DOI: 10.1016/s0161-6420(95)31052-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  170 in total

1.  Plasma kallikrein and diabetic macular edema.

Authors:  Edward P Feener
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

2.  Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).

Authors:  David J Browning
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

3.  Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.

Authors:  Atul Kumar; Subijay Sinha; Rajvardhan Azad; Yog Raj Sharma; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-09       Impact factor: 3.117

4.  Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes.

Authors:  David C Kendrick; Davis Bu; Eric Pan; Blackford Middleton
Journal:  J Am Med Inform Assoc       Date:  2007-02-28       Impact factor: 4.497

5.  A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.

Authors:  D Thomas; C Bunce; C Moorman; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 6.  The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Benjamin A Allaire; Michael S Song; Ronald Klein; Jinan B Saaddine
Journal:  Health Serv Res       Date:  2011-04-14       Impact factor: 3.402

Review 7.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

8.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

9.  [Diagnosis, therapy and follow up of diabetic eye disease].

Authors:  Michael Stur; Stefan Egger; Anton Haas; Gerhard Kieselbach; Stefan Mennel; Reinhard Michl; Michael Roden; Ulrike Stolba; Andreas Wedrich
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

Review 10.  Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.

Authors:  David J Ramsey; G B Arden
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.